William Blair & Company
IMUX icon

William Blair & Company’s Immunic IMUX Stock Holding History

William Blair & Company’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-249
Closed -$592K – 1544
2017
Q4 		$592K Hold
249
– – ﹤0.01% 909
2017
Q3 		$502K Hold
249
– – ﹤0.01% 934
2017
Q2 		$289K Buy
249
+100
+67% +$133K ﹤0.01% 1204
2017
Q1 		$277K Hold
149
– – ﹤0.01% 1107
2016
Q4 		$259K Hold
149
– – ﹤0.01% 1058
2016
Q3 		$364K Hold
149
– – ﹤0.01% 945
2016
Q2 		$369K Hold
149
– – ﹤0.01% 911
2016
Q1 		$540K Hold
149
– – 0.01% 769
2015
Q4 		$685K Hold
149
– – 0.01% 729
2015
Q3 		$240K Sell
149
-8
-5% -$40K ﹤0.01% 1217
2015
Q2 		$1.32M Buy
+157
New +$1.5M ﹤0.01% 1493
2015
Q1 		– Sell
-44
Closed -$443K – 2171
2014
Q4 		$443K Buy
+44
New +$339K ﹤0.01% 1715

Other funds holding IMUX

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

William Blair & Company's IMUX Position: Q1 2018 in Review

William Blair & Company sold out of Immunic (IMUX) in Q1 2018, closing a stake of 249 shares — an estimated $592K sold.

William Blair & Company first reported a position in IMUX in Q4 2014 and held it in 12 quarters. The position peaked at $1.32M in Q2 2015. 58 funds tracked by Wall St. Rank hold IMUX as of Q1 2018.

  • William Blair & Company reported no remaining Immunic position as of Q1 2018 after selling out during the quarter.
  • William Blair & Company sold 249 Immunic shares in Q1 2018, an estimated $592K.
  • William Blair & Company first reported a position in Immunic in Q4 2014 and held it in 12 quarters.
  • William Blair & Company's Immunic position peaked at $1.32M in Q2 2015.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q1 2018.

Based on William Blair & Company's 13F filing for Q1 2018, filed 15 May 2018.